Synergy Pharmaceuticals Inc. (SGYP) announced after the close Tuesday that it intends to sell $125 million of its common stock in an underwritten public offering. The stock is now down 0.81 on 3.9 million shares.
Synergy Pharmaceuticals climbed during the first hour of trade Tuesday and advanced further in the early afternoon. Shares finished up by 0.53 at $7.07 on above average volume. The stock rose above a 1-month trading range and set a new high for the year.
For comments and feedback: editorial@rttnews.com